Ellen T. Matloff on Genetic Recommendations for BRCA1/2 Carriers

Article

Ellen T. Matloff, MS, CGC, director, Yale Cancer Genetic Counseling Program at the Yale School of Medicine/Yale Cancer Center, discusses options for BRCA1/2 carriers who are looking to reduce their risk of ovarian cancer.

Ellen T. Matloff, MS, CGC, director, Yale Cancer Genetic Counseling Program at the Yale School of Medicine/Yale Cancer Center, discusses options for BRCA1/2 carriers who are looking to reduce their risk of ovarian cancer.

Matloff recommends that all BRCA1/2 carriers should seek the advice of a certified genetic counselor. The counselor will sit down with the carrier and go over all of their mutations before conducting a four-generation, personal and family history assessment and going over all of their options.

If the patient has had 20 years of birth control pill use, for example, she’s already greatly reduced her risk of ovarian cancer, Matloff explains. A more personalized approached needs to be taken when discussing risk-reducing options, Matloff says.

Related Videos
Meaghan Mooney, B.S.N., RN, OCN, during the Extraordinary Healer interview
Colleen O’Leary, DNP, RN, AOCNS, EBP-C, LSSYB, in an interview with Oncology Nursing News.
Michelle H. Johann, DNP, RN, PHN, CPAN, WTA, in an interview with Oncology Nursing News explaining surgical path cards
Alison Tray, of Hartford Healthcare, discusses her team's research on a multidisciplinary team approach to manage the cancer drug shortage
Related Content
© 2024 MJH Life Sciences

All rights reserved.